Home
PCRX
PCRX News

Latest Pacira BioSciences Inc. (PCRX) News on February 23, 2025

Why Pacira (PCRX) is a Top Momentum Stock for the Long-Term

Zacks

2 days ago

Why Pacira (PCRX) is a Top Momentum Stock for the Long-Term

Pacira to Report 2024 Financial Results on Thursday February 27, 2025

GlobeNewswire

3 days ago

Pacira to Report 2024 Financial Results on Thursday February 27, 2025

Argus Research

4 days ago

PCRX: Lowering target price to $28.00

Best Value Stocks to Buy for February 11th

Zacks

12 days ago

Best Value Stocks to Buy for February 11th

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

17 days ago

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Should You Buy Pacira (PCRX) After Golden Cross?

Zacks

17 days ago

Should You Buy Pacira (PCRX) After Golden Cross?

Argus Research

18 days ago

PCRX: Raising target price to $28.00

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Zacks

19 days ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Pacira Announces Updates to Board of Directors

GlobeNewswire

24 days ago

Pacira Announces Updates to Board of Directors

Argus Research

25 days ago

PCRX: Raising target price to $27.00

Argus Research

a month ago

PCRX: Raising target price to $24.00

Pacira BioSciences Strengthens Executive Leadership Team with Two Key Appointments

GlobeNewswire

a month ago

Pacira BioSciences Strengthens Executive Leadership Team with Two Key Appointments

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Zacks

a month ago

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Argus Research

a month ago

PCRX: Raising target price to $22.00

PCRX Stock Rises 11% on Upbeat Q4 Preliminary Product Sales

Zacks

a month ago

PCRX Stock Rises 11% on Upbeat Q4 Preliminary Product Sales

Pacira Announces New Five-Year Objectives to Accelerate Transition into an Innovative Biopharmaceutical Organization

GlobeNewswire

a month ago

Pacira Announces New Five-Year Objectives to Accelerate Transition into an Innovative Biopharmaceutical Organization

Pacira BioSciences Secures FDA Approval For New iovera SmartTip to Manage Chronic Low Back Pain

Benzinga

a month ago

Pacira BioSciences Secures FDA Approval For New iovera SmartTip to Manage Chronic Low Back Pain

Pacira BioSciences Receives FDA 510k Clearance for New iovera° SmartTip to Manage Chronic Low Back Pain via Long-lasting Medial Branch Nerve Block

GlobeNewswire

2 months ago

Pacira BioSciences Receives FDA 510k Clearance for New iovera° SmartTip to Manage Chronic Low Back Pain via Long-lasting Medial Branch Nerve Block

Pacira BioSciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

2 months ago

Pacira BioSciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Argus Research

2 months ago

PCRX: Lowering target price to $15.00

Here's Why Pacira (PCRX) is a Strong Momentum Stock

Zacks

2 months ago

Here's Why Pacira (PCRX) is a Strong Momentum Stock

Argus Research

2 months ago

PCRX: What does Argus have to say about PCRX?

DOMA Perpetual Capital Management Announces Intent to Nominate Four Highly Qualified, Independent Director Candidates at 2025 Annual Meeting of Pacira BioSciences, Inc.

PR Newswire

2 months ago

DOMA Perpetual Capital Management Announces Intent to Nominate Four Highly Qualified, Independent Director Candidates at 2025 Annual Meeting of Pacira BioSciences, Inc.

Argus Research

2 months ago

PCRX: Raising target price to $16.00

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire

3 months ago

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Argus Research

3 months ago

PCRX: What does Argus have to say about PCRX?

Pacira Awarded New U.S. Patent Covering EXPAREL Composition

GlobeNewswire

3 months ago

Pacira Awarded New U.S. Patent Covering EXPAREL Composition

Why Pacira (PCRX) is a Top Momentum Stock for the Long-Term

Zacks

3 months ago

Why Pacira (PCRX) is a Top Momentum Stock for the Long-Term

Argus Research

3 months ago

PCRX: What does Argus have to say about PCRX?

Pacira Announces 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee

GlobeNewswire

3 months ago

Pacira Announces 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee

Argus Research

3 months ago

PCRX: Lowering target price to $13.00

Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences

GlobeNewswire

3 months ago

Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 11/11/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 11/08/2024

Pacira Q3 Earnings Top, Revenues Miss Despite Exparel Sales Growth

Zacks

3 months ago

Pacira Q3 Earnings Top, Revenues Miss Despite Exparel Sales Growth

Thomson Reuters StreetEvents

4 months ago

Q3 2024 Pacira Biosciences Inc Earnings Call

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 11/07/2024

Pacira BioSciences Inc (PCRX) Q3 2024 Earnings Call Highlights: Strong Financial Position ...

GuruFocus.com

4 months ago

Pacira BioSciences Inc (PCRX) Q3 2024 Earnings Call Highlights: Strong Financial Position ...

Associated Press Finance

4 months ago

Pacira: Q3 Earnings Snapshot

Pacira BioSciences Reports Third Quarter 2024 Financial Results

GlobeNewswire

4 months ago

Pacira BioSciences Reports Third Quarter 2024 Financial Results

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 11/06/2024

Argus Research

4 months ago

PCRX: What does Argus have to say about PCRX?

Pacira BioSciences Inc (PCRX) Q3 2024: Everything You Need To Know Ahead Of Earnings

GuruFocus.com

4 months ago

Pacira BioSciences Inc (PCRX) Q3 2024: Everything You Need To Know Ahead Of Earnings

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 11/05/2024

Centers for Medicare and Medicaid Services (CMS) Establishes Additional Payment for iovera in Outpatient Settings

GlobeNewswire

4 months ago

Centers for Medicare and Medicaid Services (CMS) Establishes Additional Payment for iovera in Outpatient Settings

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 11/04/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 11/01/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 10/31/2024

Pacira to Report Third Quarter 2024 Financial Results on Wednesday November 6, 2024

GlobeNewswire

4 months ago

Pacira to Report Third Quarter 2024 Financial Results on Wednesday November 6, 2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 10/30/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 10/29/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 10/28/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 10/25/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 10/24/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 10/23/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 10/22/2024

Are Options Traders Betting on a Big Move in Pacira BioSciences (PCRX) Stock?

Zacks

4 months ago

Are Options Traders Betting on a Big Move in Pacira BioSciences (PCRX) Stock?

Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer

GlobeNewswire

4 months ago

Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 10/21/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 10/18/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 10/17/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 10/16/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 10/15/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 10/14/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 10/11/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 10/10/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 10/09/2024

Argus Research

4 months ago

PCRX: Raising target price to $13.00

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 10/08/2024

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire

5 months ago

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 10/07/2024

The three-year loss for Pacira BioSciences (NASDAQ:PCRX) shareholders likely driven by its shrinking earnings

Simply Wall St.

5 months ago

The three-year loss for Pacira BioSciences (NASDAQ:PCRX) shareholders likely driven by its shrinking earnings

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 10/04/2024

Pacira BioSciences Announces New Product-Specific J-Code for EXPAREL Effective January 1, 2025

GlobeNewswire

5 months ago

Pacira BioSciences Announces New Product-Specific J-Code for EXPAREL Effective January 1, 2025

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 10/03/2024

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 10/02/2024

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 10/01/2024

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 09/30/2024

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 09/27/2024

Pacira Announces the Presentation of 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee

GlobeNewswire

5 months ago

Pacira Announces the Presentation of 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 09/26/2024

DOMA Perpetual Sends Letter to Board of Directors of Pacira Biosciences to Immediately Accelerate and Increase its Share Buyback Program to Enhance Return to Shareholders

PR Newswire

5 months ago

DOMA Perpetual Sends Letter to Board of Directors of Pacira Biosciences to Immediately Accelerate and Increase its Share Buyback Program to Enhance Return to Shareholders

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 09/25/2024

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 09/24/2024

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 09/23/2024

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 09/20/2024

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 09/19/2024

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 09/18/2024

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 09/17/2024

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 09/16/2024

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 09/13/2024

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 09/12/2024

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 09/11/2024

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 09/10/2024

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire

5 months ago

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Zacks

5 months ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 09/09/2024

Argus Research

6 months ago

Daily – Vickers Top Insider Picks for 09/06/2024

Argus Research

6 months ago

Daily – Vickers Top Insider Picks for 09/05/2024

Argus Research

6 months ago

Daily – Vickers Top Insider Picks for 09/04/2024

Share on Social Networks: